Assignee
CERUS CORP
US·68 granted patents·27 pending applications·2,509 citations·filing 1994–2025
Top patents by PatentIndex Score
95 records- 0195US6410219B1Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding groupCERUS CORP·Filed 2000·Granted Jun 25, 2002·54 cites·78 claims
- 0295US6258319B1Device and method for photoactivationCERUS CORP·Filed 1998·Granted Jul 10, 2001·120 cites·5 claims
- 0394US7611831B2Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrixCERUS CORP·Filed 2005·Granted Nov 3, 2009·29 cites·56 claims
- 0494US6461567B1Device and method for photoactivationCERUS CORP·Filed 2001·Granted Oct 8, 2002·27 cites·4 claims
- 0593US6544727B1Methods and devices for the removal of psoralens from blood productsCERUS CORP·Filed 1996·Granted Apr 8, 2003·154 cites·47 claims
- 0692US7655392B2Quenching methods for red blood cell inactivation processCERUS CORP·Filed 2005·Granted Feb 2, 2010·30 cites·20 claims
- 0792US6680025B2Device and method for photoactivationCERUS CORP·Filed 2002·Granted Jan 20, 2004·31 cites·3 claims
- 0891US6709810B2Methods for quenching pathogen inactivators in biological materialsCERUS CORP·Filed 2001·Granted Mar 23, 2004·39 cites·20 claims
- 0990US10357516B2Pathogen-inactivated red blood cell compositionsCERUS CORP·Filed 2017·Granted Jul 23, 2019·13 cites·22 claims
- 1089US10842818B2Methods for preparing platelet productsCERUS CORP·Filed 2015·Granted Nov 24, 2020·10 cites·31 claims
- 1189US9713627B2Pathogen-inactivated red blood cell compositionsCERUS CORP·Filed 2014·Granted Jul 25, 2017·15 cites·27 claims
- 1289US6455286B1Psoralens for pathogen inactivationCERUS CORP·Filed 2000·Granted Sep 24, 2002·26 cites·6 claims
- 1389US6171777B1Treating blood or blood product with a compound having a mustard and a nucleic acid binding moietyCERUS CORP·Filed 1995·Granted Jan 9, 2001·68 cites·13 claims
- 1489US5691132AMethod for inactivating pathogens in red cell compositions using quinacrine mustardCERUS CORP·Filed 1994·Granted Nov 25, 1997·83 cites·7 claims
- 1588US11883544B2System and methods for implementing a biological fluid treatment deviceCERUS CORP·Filed 2020·Granted Jan 30, 2024·3 cites·19 claims
- 1688US7293985B2Methods for quenching pathogen inactivators in biological materialsCERUS CORP·Filed 2004·Granted Nov 13, 2007·25 cites·24 claims
- 1788US7037642B2Removing compounds from blood products with porous particles immobilized in a matrixCERUS CORP·Filed 2001·Granted May 2, 2006·53 cites·46 claims
- 1887US12343436B2System and methods for implementing a biological fluid treatment deviceCERUS CORP·Filed 2023·Granted Jul 1, 2025·1 cites·20 claims
- 1987US6469052B2Compounds for the photodecontamination of pathogens in bloodCERUS CORP·Filed 2001·Granted Oct 22, 2002·33 cites·20 claims
- 2087US6281225B1Inhibiting proliferation of arterial smooth muscle cellsCERUS CORP·Filed 1999·Granted Aug 28, 2001·81 cites·11 claims
- 2187US6270952B1Methods for quenching pathogen inactivators in biological materialsCERUS CORP·Filed 1998·Granted Aug 7, 2001·61 cites·117 claims
- 2286US12214092B2Systems and methods for treating biological fluidsCERUS CORP·Filed 2022·Granted Feb 4, 2025·1 cites·57 claims
- 2386US10799533B2Plasma compositions and methods of use thereofCERUS CORP·Filed 2016·Granted Oct 13, 2020·11 cites·16 claims
- 2486US6143490ATreating blood or blood product with a compound having a mustard and a nucleic acid binding moietyCERUS CORP·Filed 1995·Granted Nov 7, 2000·48 cites·21 claims
- 2585US11554185B2Systems and methods for treating biological fluidsCERUS CORP·Filed 2018·Granted Jan 17, 2023·5 cites·44 claims
- 2685US11096963B2Cryoprecipitate compositions and methods of preparation thereofCERUS CORP·Filed 2016·Granted Aug 24, 2021·10 cites·22 claims
- 2785US6514987B1Frangible compounds for pathogen inactivationCERUS CORP·Filed 2000·Granted Feb 4, 2003·52 cites·12 claims
- 2883US6951713B2Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrixCERUS CORP·Filed 2001·Granted Oct 4, 2005·47 cites·45 claims
- 2983US5683661ADevice and method for photoactivationCERUS CORP·Filed 1995·Granted Nov 4, 1997·41 cites·3 claims
- 3082US6686480B2Compounds for the photodecontamination of pathogens in bloodCERUS CORP·Filed 2002·Granted Feb 3, 2004·33 cites·2 claims
- 3182US6420570B1Psoralen compoundsCERUS CORP·Filed 2001·Granted Jul 16, 2002·34 cites·2 claims
- 3281US12282015B2Systems and methods for testing and screening using compound bound substratesCERUS CORP·Filed 2023·Granted Apr 22, 2025·0 cites·10 claims
- 3381US6586749B2Device and method for photoactivationCERUS CORP·Filed 2002·Granted Jul 1, 2003·30 cites·76 claims
- 3480US6133460APsoralens for pathogen inactivationCERUS CORP·Filed 1998·Granted Oct 17, 2000·36 cites·12 claims
- 3580US5593823AMethod for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralensCERUS CORP·Filed 1994·Granted Jan 14, 1997·109 cites·23 claims
- 3679US12011510B2Biological fluid treatment systemsCERUS CORP·Filed 2020·Granted Jun 18, 2024·1 cites·48 claims
- 3779US7068361B2Apparatus, systems and methods for processing and treating a biological fluid with lightCERUS CORP·Filed 2002·Granted Jun 27, 2006·24 cites·11 claims
- 3878US5908742ASynthetic media for blood componentsCERUS CORP·Filed 1996·Granted Jun 1, 1999·81 cites·7 claims
- 3976US6017691A4'-primary aminopsoralen and platelet compositionsCERUS CORP·Filed 1996·Granted Jan 25, 2000·58 cites·5 claims
- 4076US5712085A5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic mediumCERUS CORP·Filed 1995·Granted Jan 27, 1998·57 cites·2 claims
- 4175US2026048161A1System and methods for implementing a biological fluid treatment deviceCERUS CORP·Filed 2025·Application pending·0 cites
- 4275US2025216379A1Systems and methods for testing and screening using compound bound substratesCERUS CORP·Filed 2025·Application pending·0 cites
- 4374US12558442B2Biological fluid treatment systemsCERUS CORP·Filed 2024·Granted Feb 24, 2026·0 cites·35 claims
- 4474US7105093B2Processing set and methods for processing and treating a biological fluidCERUS CORP·Filed 2002·Granted Sep 12, 2006·17 cites·12 claims
- 4574US2025345471A1Systems and methods for treating biological fluidsCERUS CORP·Filed 2024·Application pending·0 cites
- 4673US6949753B2Device and method for photoactivationCERUS CORP·Filed 2003·Granted Sep 27, 2005·15 cites·4 claims
- 4773US6433343B1Device and method for photoactivationCERUS CORP·Filed 1999·Granted Aug 13, 2002·69 cites·8 claims
- 4873US5709991AProralen inactivation of microorganisms and psoralen removalCERUS CORP·Filed 1995·Granted Jan 20, 1998·95 cites·14 claims
- 4973US5625079ASynthesizing psoralen compounds useful as intermediatesCERUS CORP·Filed 1995·Granted Apr 29, 1997·48 cites·2 claims
- 5072US5854967ADevice and method for photoactivationCERUS CORP·Filed 1997·Granted Dec 29, 1998·27 cites·10 claims
Showing the top 50 of 95 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CERUS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →